Key result
Biomedicus centrifugal pump support for cardiogenic shock yields survival reaching ~47% depending on etiology.
Why the study?
Experience and outcomes of mechanical circulatory support using the Biomedicus centrifugal pump in patients with cardiogenic shock were evaluated over seven years.
Population
61 patients aged 29 to 78 years with cardiogenic shock of various etiologies
Comparison
No comparator; observational experience with centrifugal pump support
Design
Cohort study
Follow-up
1 to 347 hours (duration of pump support)
Authors
Loading...
Centrifugal pump support yields modest, etiology-dependent survival in cardiogenic shock; leaves open optimal device selection without randomized evidence.
Cohort (n=61)
Mechanical circulatory support with a centrifugal pump in cardiogenic shock yields modest survival rates, with better outcomes in postcardiotomy shock compared to post-MI or other etiologies, but is limited by high rates of bleeding and multiorgan failure.
El‐Banayosy et al. (1995) conducted a cohort in Cardiogenic shock (n=61). Biomedicus centrifugal pump was evaluated on Survival. Mechanical circulatory support with the Biomedicus centrifugal pump for cardiogenic shock resulted in survival rates ranging from 18.1% to 46.7% depending on the etiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: